Progressive supranuclear palsy (PSP) can be difficult to differentiate from Parkinson's disease (PD) and multiple-system atrophy of the Parkinson type (MSA-P). Studies suggest a close relationship ...

Pratap Chand, MD, DM, FRCP, University of Louisville School of Medicine, Division of Movement Disorders, Frazier Rehab Neuroscience Institute, 220 Abraham Flexner Way, Ste 1503 Louisville, KY ...

Progressive supranuclear palsy (PSP) is an uncommon brain disorder. It affects many areas of function, including a person's ...

New Hope for Progressive Supranuclear Palsy with Innovative Trial $75 million NIH grant could lead to the first effective drugs for a condition with few treatment options. ... In addition, data, ...

A machine learning model differentiated Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. AUROCs and predictive values for distinguishing Parkinson's from mimics ...

A novel PET imaging study has identified unique patterns of neuroinflammation in patients with progressive apraxia of speech ...

More information: Miriam Scarpa et al, Post mortem validation and mechanistic study of UCB‐J in progressive supranuclear palsy patients' brains, Alzheimer's & Dementia (2024). DOI: 10.1002/alz.14409 ...

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration ... MRI, single-photon emission computed tomography (SPECT) and PET, may improve diagnostic accuracy, ...